Wpg Advisers, LLC Catalyst Pharmaceuticals, Inc. Put Options Transaction History
Wpg Advisers, LLC
- $107 Billion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CPRX
# of Institutions
387Shares Held
99.2MCall Options Held
37KPut Options Held
20.5K-
Black Rock Inc. New York, NY18.7MShares$454 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.5MShares$206 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$134 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.42MShares$83.2 Million2.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.14MShares$76.2 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.5B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...